FAQ: Nutriband Inc. Strengthens Pharma Footprint Through Key Alliances

What is Nutriband Inc. known for?

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products, with its lead product being an abuse deterrent fentanyl patch incorporating its AVERSA(TM) technology.

What are the new strategic partnerships Nutriband has entered into?

Nutriband has partnered with Charlotte FC to build brand visibility for its AI Tape and AVERSA(TM) technology, and deepened its collaboration with Kindeva Drug Delivery for the development of Aversa(TM) Fentanyl.

What is AVERSA(TM) technology?

AVERSA(TM) is Nutriband’s proprietary abuse-deterrent technology that can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Why is the partnership with Kindeva Drug Delivery significant?

The partnership focuses on combining Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch, aiming to develop Aversa(TM) Fentanyl, which could enhance safety in pain management.

How does Nutriband aim to benefit from these partnerships?

Through these alliances, Nutriband aims to diversify its revenue streams and reinforce its position as a leader in transdermal drug delivery solutions by expanding its market presence and manufacturing capabilities.

Where can I find more information about Nutriband Inc.?

For more information about Nutriband Inc., visit their website at www.Nutriband.com or check the latest news and updates at https://ibn.fm/NTRB.

What is the significance of Nutriband’s collaboration with Charlotte FC?

The collaboration with Charlotte FC is aimed at building brand visibility for Nutriband’s products, particularly its AI Tape and AVERSA(TM) technology, potentially expanding its reach in the health and wellness industry.

What makes AVERSA(TM) technology unique?

AVERSA(TM) technology is believed to have the potential to be the world’s first and only abuse deterrent patch platform for managing chronic pain, making it a groundbreaking development in transdermal drug delivery.